意外
发表于 2025-3-30 09:29:33
http://reply.papertrans.cn/43/4285/428431/428431_51.png
CYT
发表于 2025-3-30 14:00:30
http://reply.papertrans.cn/43/4285/428431/428431_52.png
摘要记录
发表于 2025-3-30 20:14:15
F. Yang,G. R. Hayes,R. T. Phillips,K. P. O’Donnell regimens including high dose cytarabine are appropriate for patients with myeloid EML. Presence of EML should not be used alone to determine need for stem cell transplant (SCT). Risk-adapted treatment should utilize genetic markers and disease response that includes assessment of remission in EML s
Costume
发表于 2025-3-30 22:46:40
R. Hellmann,A. Euteneur,S. G. Hense,J. Feldmann,P. Thomas,E. O. Göbel,A. Waag,G. Landwehr9–1886, 2020). This correlates with approximately one in every three pediatric AML patients dying, and the price for cure among survivors includes a significant increase in long-term chronic health conditions (Bhatt et al., Leukemia 35(8):2258–2273, 2021). Further improvement is badly needed. Within
高原
发表于 2025-3-31 00:53:36
Yu. L. Ivanov,G. V. Churakov,V. M. Ustinov,A. E. Zhukov regimens including high dose cytarabine are appropriate for patients with myeloid EML. Presence of EML should not be used alone to determine need for stem cell transplant (SCT). Risk-adapted treatment should utilize genetic markers and disease response that includes assessment of remission in EML s
过滤
发表于 2025-3-31 05:59:35
http://reply.papertrans.cn/43/4285/428431/428431_56.png
Daily-Value
发表于 2025-3-31 11:09:53
http://reply.papertrans.cn/43/4285/428431/428431_57.png
notion
发表于 2025-3-31 15:22:00
http://reply.papertrans.cn/43/4285/428431/428431_58.png
标准
发表于 2025-3-31 18:10:49
http://reply.papertrans.cn/43/4285/428431/428431_59.png
dearth
发表于 2025-4-1 01:16:15
Jürgen Schilp,Tilmann Kuhnf existing legislation is required in order to make the EU liability framework fit for the current and forthcoming technological and commercial developments. In addition, this chapter provides an extensive review of the Commission’s 2020 Report on the safety and liability implications of AI, IoT and